Ocugen to Present at the 2018 BIO International Convention

Boston

MALVERN, PA — Ocugen, Inc.Ocugen, Inc., a rapidly growing ophthalmology company developing a rich clinical pipeline of innovative therapies that address rare and underserved ocular diseases, today announced that it will present at the 2018 BIO International Convention, taking place June 4-7, 2018, in Boston.

Shankar Musunuri, Ph.D., Chairman, CEO and Co-Founder of Ocugen will highlight Ocugen’s industry-leading ophthalmology pipeline, which includes small molecules, highly targeted biologics, and a novel gene therapy platform.  Ocugen anticipates entering Phase 3 clinical trials in the coming months for its two lead programs in ocular graft versus host disease and dry eye disease.

Presentation Details:

Date: Tuesday, June 5, 2018
Time: 3:45pm ET
Location: The Boston Convention and Exhibition Center, Theater 1

Source: Ocugen, Inc., 5 Great Valley Pkwy Suite 160, Malvern PA 19355

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Buy Us a Cup of Coffee